0001209191-21-024234.txt : 20210401
0001209191-21-024234.hdr.sgml : 20210401
20210401181957
ACCESSION NUMBER: 0001209191-21-024234
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210330
FILED AS OF DATE: 20210401
DATE AS OF CHANGE: 20210401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xu Stella
CENTRAL INDEX KEY: 0001728741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40288
FILM NUMBER: 21799758
MAIL ADDRESS:
STREET 1: C/O ARMO BIOSCIENCES, INC.
STREET 2: 575 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Design Therapeutics, Inc.
CENTRAL INDEX KEY: 0001807120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823929248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 991C LOMAS SANTA FE #436
CITY: SOLANA BEACH
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-293-4900
MAIL ADDRESS:
STREET 1: 991C LOMAS SANTA FE #436
CITY: SOLANA BEACH
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-30
0
0001807120
Design Therapeutics, Inc.
DSGN
0001728741
Xu Stella
C/O DESIGN THERAPEUTICS, INC.
6005 HIDDEN VALLEY ROAD, SUITE 110
CARLSBAD
CA
92011
1
0
1
0
Common Stock
2021-03-30
4
C
0
4439839
A
4439839
I
See footnote
Common Stock
2021-03-30
4
C
0
280991
A
4720830
I
See footnote
Common Stock
2021-03-30
4
P
0
10000
20.00
A
4730830
I
By spouse
Series A Preferred Stock
2021-03-30
4
C
0
7236938
0.00
D
Common Stock
4439839
0
I
See footnote
Series B Preferred Stock
2021-03-30
4
C
0
458016
0.00
D
Common Stock
280991
0
I
See footnote
All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C. Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P. Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P., except to the extent of her pecuniary interest.
The shares were purchased in the Issuer's initial public offering.
/s/ Mustapha Parekh, Attorney-in-Fact
2021-03-31